According to Maipu Medical's announcement, Shenzhen Kaiying Technology Co., Ltd., the shareholder holding more than 5% of the company's shares, has expired. Shenzhen Kaiying originally planned to reduce its holdings by no more than 300,000 shares through centralized bidding transactions, accounting for 0.4474% of the company's total share capital at the time. The holdings reduction period is from August 7, 2026 to September 1, 2026. Shenzhen Kaiying reduced its holdings by 801,000 shares through centralized bidding, with an average reduction price of 56.00 yuan/share, accounting for 0.1194% of the company's current total share capital. After this reduction in holdings, Shenzhen Kaiying held 3.8361 million shares of the company, accounting for 5.7185% of the company's total share capital. This reduction in holdings will not lead to a change in the company's control and will not affect corporate governance and ongoing operations.

According to Maipu Medical's announcement, Shenzhen Kaiying Technology Co., Ltd., the shareholder holding more than 5% of the company's shares, has expired. Shenzhen Kaiying originally planned to reduce its holdings by no more than 300,000 shares through centralized bidding transactions, accounting for 0.4474% of the company's total share capital at the time. The holdings reduction period is from August 7, 2026 to September 1, 2026. Shenzhen Kaiying reduced its holdings by 801,000 shares through centralized bidding, with an average reduction price of 56.00 yuan/share, accounting for 0.1194% of the company's current total share capital. After this reduction in holdings, Shenzhen Kaiying held 3.8361 million shares of the company, accounting for 5.7185% of the company's total share capital. This reduction in holdings will not lead to a change in the company's control and will not affect corporate governance and ongoing operations.